Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.62B |
| 2 |
Apple
AAPL
|
+$747M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$655M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$427M |
| 5 |
Walt Disney
DIS
|
+$341M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$2.63B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 3 |
Yum! Brands
YUM
|
+$734M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$558M |
| 5 |
Visa
V
|
+$398M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.59% |
| 2 | Technology | 8.45% |
| 3 | Healthcare | 7.6% |
| 4 | Consumer Discretionary | 6.86% |
| 5 | Energy | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Simpson Manufacturing
SSD
$7.82B
| $3.57M | ﹤0.01% |
93,408
+40,672
| +77% | +$1.38M |
|
2952
CALL
United Therapeutics
UTHR
$25.7B
| $3.57M | ﹤0.01% |
32,000
-300
| -0.9% | -$38K |
|
|
FPRX
2953
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $3.56M | ﹤0.01% |
87,560
-92,278
| -51% | -$3.17M |
|
|
AL
2954
DELISTED
Air Lease Corp
AL
| $3.55M | ﹤0.01% |
110,660
-24,848
| -18% | -$706K |
|
|
TRCO
2955
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
| $3.55M | ﹤0.01% |
92,596
-79,611
| -46% | -$2.69M |
|
|
SIR
2956
DELISTED
SELECT INCOME REIT
SIR
| $3.55M | ﹤0.01% |
350,325
+46,071
| +15% | +$409K |
|
2957
PUT
American Electric Power
AEP
$69.8B
| $3.55M | ﹤0.01% |
53,400
-26,500
| -33% | -$1.64M |
|
2958
CALL
BHP
BHP
$211B
| $3.55M | ﹤0.01% |
153,465
-15,806
| -9% | -$335K |
|
|
FNGN
2959
DELISTED
Financial Engines, Inc.
FNGN
| $3.54M | ﹤0.01% |
112,730
+51,404
| +84% | +$1.43M |
|
|
TLRD
2960
CALL
DELISTED
Tailored Brands, Inc.
TLRD
| $3.53M | ﹤0.01% |
+197,400
| New | +$3.04M |
|
|
FIT
2961
CALL
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $3.51M | ﹤0.01% |
231,800
-95,600
| -29% | -$1.52M |
|
2962
PUT
Direxion Daily Financial Bull 3x ETF
FAS
$2.39B
| $3.51M | ﹤0.01% |
141,700
-173,500
| -55% | -$3.81M |
|
2963
BioCryst Pharmaceuticals
BCRX
$2.25B
| $3.5M | ﹤0.01% |
1,237,418
+155,133
| +14% | +$688K |
|
2964
CALL
Danaher
DHR
$139B
| $3.5M | ﹤0.01% |
54,901
-457,062
| -89% | -$27.2M |
|
|
ICPT
2965
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $3.5M | ﹤0.01% |
27,234
-16,512
| -38% | -$1.95M |
|
|
JNS
2966
DELISTED
Janus Capital Group Inc
JNS
| $3.5M | ﹤0.01% |
239,148
-203,171
| -46% | -$2.64M |
|
2967
MasterCraft Boat Holdings
MCFT
$577M
| $3.49M | ﹤0.01% |
247,981
+427
| +0.2% | +$5.43K |
|
|
CDTX
2968
DELISTED
Cidara Therapeutics
CDTX
| $3.49M | ﹤0.01% |
13,731
-13,559
| -50% | -$3.12M |
|
|
GIMO
2969
DELISTED
Gigamon Inc.
GIMO
| $3.49M | ﹤0.01% |
112,442
+19,193
| +21% | +$501K |
|
|
EVDY
2970
DELISTED
Everyday Health, Inc.
EVDY
| $3.48M | ﹤0.01% |
622,357
-1,940,188
| -76% | -$9.55M |
|
2971
CALL
Eastman Chemical
EMN
$8.18B
| $3.48M | ﹤0.01% |
48,200
-46,200
| -49% | -$3.03M |
|
2972
Century Aluminum
CENX
$4.41B
| $3.48M | ﹤0.01% |
493,293
+455,178
| +1,194% | +$2.52M |
|
2973
Inogen
INGN
$180M
| $3.48M | ﹤0.01% |
77,298
+26,833
| +53% | +$956K |
|
2974
CALL
Kroger
KR
$35.7B
| $3.48M | ﹤0.01% |
90,900
-597,200
| -87% | -$23.1M |
|
|
CIT
2975
PUT
DELISTED
CIT Group Inc.
CIT
| $3.48M | ﹤0.01% |
112,000
+101,400
| +957% | +$3.2M |
|
Similar funds
Goldman Sachs's Q1 2016 Portfolio in Review
As of Q1 2016, Goldman Sachs held 7,717 positions worth $304B, down 4.6% from $319B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $11.3B in Q1 2016, closing 656 positions and reducing 3,244 holdings. Its most notable exit was CHUBB CORPORATION, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Financials at 8.6% of assets, down from 9.2% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Goldman Sachs opened a new position in Welbilt, Inc. worth $36.5M.
- Goldman Sachs's largest Q1 2016 buy was Welbilt, Inc.: 2,476,061 shares worth $36.5M.
- Goldman Sachs added most to Pfizer in Q1 2016, an estimated $1.62B increase.
- Goldman Sachs's biggest Q1 2016 reduction was Zimmer Biomet, cutting an estimated $2.63B.
- Goldman Sachs fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $383M.
- Goldman Sachs's ten largest holdings make up 15% of its $304B portfolio in Q1 2016.
- Goldman Sachs opened 593 new positions and closed 656 in Q1 2016.
- Goldman Sachs's portfolio value fell 4.6% quarter-over-quarter to $304B.
Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.